On the contrary raloxifene, which has ER agonistic effect in bone, antagonistic effect in breast, and neutral effect in endometrium [38, 39], similarly to ospemifene, has shown a potential effect in curing both cancer and dysplasia in the cervix in transgenic mouse model [40]. This evidence concerns the gene ESR1 and dysplasia.